Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Is insulin growth factor-1 the future for treating autism spectrum disorder and/or schizophrenia?

Bou Khalil R.

Med Hypotheses. 2017 Feb;99:23-25. doi: 10.1016/j.mehy.2016.12.004. Epub 2016 Dec 18.

PMID:
28110691
2.

Gain-of-function missense variant in SLC12A2, encoding the bumetanide-sensitive NKCC1 cotransporter, identified in human schizophrenia.

Merner ND, Mercado A, Khanna AR, Hodgkinson A, Bruat V, Awadalla P, Gamba G, Rouleau GA, Kahle KT.

J Psychiatr Res. 2016 Jun;77:22-6. doi: 10.1016/j.jpsychires.2016.02.016. Epub 2016 Feb 27.

PMID:
26955005
3.

Characteristics of the cation cotransporter NKCC1 in human brain: alternate transcripts, expression in development, and potential relationships to brain function and schizophrenia.

Morita Y, Callicott JH, Testa LR, Mighdoll MI, Dickinson D, Chen Q, Tao R, Lipska BK, Kolachana B, Law AJ, Ye T, Straub RE, Weinberger DR, Kleinman JE, Hyde TM.

J Neurosci. 2014 Apr 2;34(14):4929-40. doi: 10.1523/JNEUROSCI.1423-13.2014.

4.

DISC1 and SLC12A2 interaction affects human hippocampal function and connectivity.

Callicott JH, Feighery EL, Mattay VS, White MG, Chen Q, Baranger DA, Berman KF, Lu B, Song H, Ming GL, Weinberger DR.

J Clin Invest. 2013 Jul;123(7):2961-4. doi: 10.1172/JCI67510.

5.

Association of CTXN3-SLC12A2 polymorphisms and schizophrenia in a Thai population.

Panichareon B, Nakayama K, Iwamoto S, Thurakitwannakarn W, Sukhumsirichart W.

Behav Brain Funct. 2012 May 29;8:27. doi: 10.1186/1744-9081-8-27.

6.

Interplay between DISC1 and GABA signaling regulates neurogenesis in mice and risk for schizophrenia.

Kim JY, Liu CY, Zhang F, Duan X, Wen Z, Song J, Feighery E, Lu B, Rujescu D, St Clair D, Christian K, Callicott JH, Weinberger DR, Song H, Ming GL.

Cell. 2012 Mar 2;148(5):1051-64. doi: 10.1016/j.cell.2011.12.037.

7.

Expression of GABA signaling molecules KCC2, NKCC1, and GAD1 in cortical development and schizophrenia.

Hyde TM, Lipska BK, Ali T, Mathew SV, Law AJ, Metitiri OE, Straub RE, Ye T, Colantuoni C, Herman MM, Bigelow LB, Weinberger DR, Kleinman JE.

J Neurosci. 2011 Jul 27;31(30):11088-95. doi: 10.1523/JNEUROSCI.1234-11.2011.

8.

Altered expression of regulators of the cortical chloride transporters NKCC1 and KCC2 in schizophrenia.

Arion D, Lewis DA.

Arch Gen Psychiatry. 2011 Jan;68(1):21-31. doi: 10.1001/archgenpsychiatry.2010.114. Epub 2010 Sep 6.

9.

Blocking early GABA depolarization with bumetanide results in permanent alterations in cortical circuits and sensorimotor gating deficits.

Wang DD, Kriegstein AR.

Cereb Cortex. 2011 Mar;21(3):574-87. doi: 10.1093/cercor/bhq124. Epub 2010 Jul 12.

10.

Identifying gene regulatory networks in schizophrenia.

Potkin SG, Macciardi F, Guffanti G, Fallon JH, Wang Q, Turner JA, Lakatos A, Miles MF, Lander A, Vawter MP, Xie X.

Neuroimage. 2010 Nov 15;53(3):839-47. doi: 10.1016/j.neuroimage.2010.06.036. Epub 2010 Jun 22. Review.

11.

A sensitive period of mice inhibitory system to neonatal GABA enhancement by vigabatrin is brain region dependent.

Levav-Rabkin T, Melamed O, Clarke G, Farber M, Cryan JF, Dinan TG, Grossman Y, Golan HM.

Neuropsychopharmacology. 2010 Apr;35(5):1138-54. doi: 10.1038/npp.2009.219. Epub 2009 Dec 30.

12.

A genome-wide association study of schizophrenia using brain activation as a quantitative phenotype.

Potkin SG, Turner JA, Guffanti G, Lakatos A, Fallon JH, Nguyen DD, Mathalon D, Ford J, Lauriello J, Macciardi F; FBIRN.

Schizophr Bull. 2009 Jan;35(1):96-108. doi: 10.1093/schbul/sbn155. Epub 2008 Nov 20.

Supplemental Content

Loading ...
Support Center